Blog Posts

BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES

Aug 16, 2022

Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Aug 5, 2022

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Read More

SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS

Aug 5, 2022

Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI

Jul 29, 2022

Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS

Jul 22, 2022

Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to Read More

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

Jul 11, 2022

PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t Read More

BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES

Jul 8, 2022

Committee Report Shows How Brand Name Drug Company Further Juiced Profits on Read More

DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES

Jun 22, 2022

Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives Read More

SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN

Jun 17, 2022

Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade Read More

THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK

Jun 16, 2022

Federal Trade Commission Workshop Highlights How Brand Name Drug Companies Read More